The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1642
ISSUE 1642
January 24, 2022
Issue 1642
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Paxlovid for Treatment of COVID-19
January 24, 2022 (Issue: 1642)
On December 22, 2021, the FDA issued an Emergency
Use Authorization (EUA) for the investigational
antiviral drug nirmatrelvir copackaged with the HIV-1
protease inhibitor ritonavir (Paxlovid – Pfizer) for
oral treatment of mild to moderate...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.